Davis's Drug Guide
beremagene geperpavec
General
Genetic Implications:
Pronunciation:
ber-em-a-jeen jep-er-pa-vek
Trade Name(s)
- Vyjuvek
Ther. Class.
wound/ulcer/decubiti healing agent
Pharm. Class.
temporary class
gene therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Beremagene Geperpavec." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec.
Vallerand AHA, Sanoski CAC. Beremagene geperpavec. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec. Accessed August 5, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Beremagene geperpavec. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec
Vallerand AHA, Sanoski CAC. Beremagene Geperpavec [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 05]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - beremagene geperpavec
ID - 3580160
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -
